Müller Glia
November 24, 2015 4:54 pmInvestigators: Marcus Fruttiger Mark Gillies LMRI Martin Friedlander
Author Archives for Lea Scheppke
Metabolism
November 24, 2015 4:52 pmInvestigators: LMRI Lois Smith Mark Gillies Marcus Fruttiger
Genetics
November 24, 2015 4:50 pmInvestigators: Rando Allikemts Melanie Bahlo Mark Leppert
Gene Therapy
November 24, 2015 4:50 pmInvestigator: John Flannery
Blood Vessels
November 24, 2015 4:48 pmInvestigators: Martin Friedlander Lois Smith
Mark Gillies, MD, PhD
November 24, 2015 4:21 pmDr. Gillies studies Müller glia, particularly in the context of Macular Telangiectasia type 2. He has been focused on studying... View Article
Marcus Fruttiger, PhD
November 24, 2015 4:21 pmDr. Fruittger studies retinal Müller glia, retinal blood vessels, and the interaction of the two. He is also actively involved... View Article
Robert Graham, AO, FAA, MD
November 24, 2015 3:59 pmDr. Graham is the Executive Director of the Victor Chang Cardiac Research Institute and a Professor of Medicine, Cardiology. He is a fellow of the Australian Academy of Science and a foreign member of the Royal Danish Academy of Sciences and Letters. He is a scientific advisor for a number of international research councils and boards.
Joseph Gleeson, MD
November 24, 2015 3:58 pmDr. Gleeson is Professor of Neurosciences and Pediatrics at UCSD, Investigator with the Howard Hughes Medical Institute. His goal is to understand the genetic basis of diseases such as mental retardation, epilepsy and autism and develop new treatments. Dr. Gleeson is a member of the Institute of Medicine, a division of the National Academies of Science, Engineering and Medicine.
Martin Friedlander, MD, PhD
November 24, 2015 3:55 pmDr. Friedlander is the President of LMRI, Professor at TSRI, and Chief of Retina Services at the Scripps Clinic. He oversees a laboratory program that is focused on understanding basic mechanisms that regulate the growth of new blood vessels as well as cell-cell interactions that help maintain normal neuronal function in the retina. His laboratory is interested in “translational” research with the goal of identifying new therapies to treat retinal diseases, including Macular Telangiectasia type 2.
